Gestational trophoblastic neoplasia, version 2.2019: NCCN Clinical Practice Guidelines in Oncology Guidelines
| Authors: | Abu-Rustum, N. R.; Yashar, C. M.; Bean, S.; Bradley, K.; Campos, S. M.; Sook Chon, H.; Chu, C.; Cohn, D.; Crispens, M. A.; Damast, S.; Dorigo, O.; Eifel, P. J.; Fisher, C. M.; Frederick, P.; Gaffney, D. K.; Han, E.; Huh, W. K.; Lurain, J. R. 3rd; Mariani, A.; Mutch, D.; Nagel, C.; Nekhlyudov, L.; Nickles Fader, A.; Remmenga, S. W.; Reynolds, R. K.; Sisodia, R.; Tillmanns, T.; Ueda, S.; Wyse, E.; McMillian, N. R.; Scavone, J. |
| Title: | Gestational trophoblastic neoplasia, version 2.2019: NCCN Clinical Practice Guidelines in Oncology |
| Abstract: | Gestational trophoblastic neoplasia (GTN), a subset of gestational trophoblastic disease (GTD), occurs when tumors develop in the cells that would normally form the placenta during pregnancy. The NCCN Guidelines for Gestational Trophoblastic Neoplasia provides treatment recommendations for various types of GTD including hydatidiform mole, persistent post-molar GTN, low-risk GTN, highrisk GTN, and intermediate trophoblastic tumor. © 2019. All rights reserved. |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 17 |
| Issue: | 11 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2019-11-01 |
| Start Page: | 1374 |
| End Page: | 1391 |
| Language: | English |
| DOI: | 10.6004/jnccn.2019.0053 |
| PUBMED: | 31693991 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Source: Scopus |
